Home › Research › Topics › cerebral-amyloid
cerebral-amyloid
6 studies tagged cerebral-amyloid, dated 2013-10-08 to 2024-12-23. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Plasma Aβ42/Aβ40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum 2024-12-23
- The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit 2021-06-09
- Visual contrast sensitivity is associated with the presence of cerebral amyloid and tau deposition 2020-02-26
Studies
6 studies carry this tag.
Date range
2013 to 2024
Top journals
- Acta neuropathologica 1
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Brain communications 1
- Experimental & molecular medicine 1
- Neurobiology of aging 1
6 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Lumipulse plasma Aβ 42 /Aβ 40 is a scalable assay for detection of cerebral Aβ and prediction of risk for cognitive decline across the AD continuum.
-
Alzheimer's disease (AD) is the leading cause of dementia, and many studies have focused on finding effective blood biomarkers for the accurate diagnosis of this disease.
-
52/100
Visual deficits are common in neurodegenerative diseases including Alzheimer's disease.
-
Cerebral β-amyloid (cAβ) deposition and cholinergic dysfunction have been considered as major pathological and functional hallmarks of Alzheimer's disease (AD).
-
66/100
Amyloid was elevated in 26% ( n = 33) of participants.
-
The devastating effects of the still incurable Alzheimer's disease (AD) project an ever increasing shadow of burden on the health care system and society in general.